Specifically, Cordaro and coworkers reported that melanoma cells made resistant to dabrafenib exhibit peculiar stem cell-like traits accompanied by the translocation of Oct4 from the cytoplasm into the nucleus and the increased expression of the stemness marker CD20 [143]. The gene discussed is POU5F1; the disease is melanoma.